Browsing Tag
U.S. FDA Approval
2 posts
Lupin (NSE: LUPIN) secures CGT exclusivity for Risperidone LAI, launches first PrecisionSphere injectable in U.S.
Lupin Limited launches Risperidone injectable in the U.S. with 180-day CGT exclusivity, marking its entry into long-acting injectables via PrecisionSphere.
Biocon Biologics secures license agreement for biosimilar launch in US
In a landmark announcement, Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of…